These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 31293523)

  • 1. Gut Microbiota Shapes the Efficiency of Cancer Therapy.
    Ma W; Mao Q; Xia W; Dong G; Yu C; Jiang F
    Front Microbiol; 2019; 10():1050. PubMed ID: 31293523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota modulation of chemotherapy efficacy and toxicity.
    Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
    Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota, an emergent target to shape the efficiency of cancer therapy.
    Kouidhi S; Zidi O; Belkhiria Z; Rais H; Ayadi A; Ben Ayed F; Mosbah A; Cherif A; El Gaaied ABA
    Explor Target Antitumor Ther; 2023; 4(2):240-265. PubMed ID: 37205307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
    Gately S
    Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
    Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
    Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy.
    Liu X; Cheng Y; Zang D; Zhang M; Li X; Liu D; Gao B; Zhou H; Sun J; Han X; Lin M; Chen J
    Front Oncol; 2021; 11():720842. PubMed ID: 34490119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment.
    Pouncey AL; Scott AJ; Alexander JL; Marchesi J; Kinross J
    Ecancermedicalscience; 2018; 12():868. PubMed ID: 30263059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of microbiota on anticancer drugs: Current knowledge and potential applications.
    Huang J; Liu W; Kang W; He Y; Yang R; Mou X; Zhao W
    EBioMedicine; 2022 Sep; 83():104197. PubMed ID: 35933808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
    Villéger R; Lopès A; Carrier G; Veziant J; Billard E; Barnich N; Gagnière J; Vazeille E; Bonnet M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic cell death: A link between gut microbiota and anticancer effects.
    Chen W; Wang S; Wu Y; Shen X; Guo Z; Li Q; Xing D
    Microb Pathog; 2020 Apr; 141():103983. PubMed ID: 31954823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.
    Cario E
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Cancer: From Pathogenesis to Therapy.
    Vivarelli S; Salemi R; Candido S; Falzone L; Santagati M; Stefani S; Torino F; Banna GL; Tonini G; Libra M
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30609850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy.
    Cheng P; Shen P; Shan Y; Yang Y; Deng R; Chen W; Lu Y; Wei Z
    Front Cell Dev Biol; 2021; 9():626045. PubMed ID: 34568308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.
    Panebianco C; Andriulli A; Pazienza V
    Microbiome; 2018 May; 6(1):92. PubMed ID: 29789015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
    Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
    Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy.
    Chrysostomou D; Roberts LA; Marchesi JR; Kinross JM
    Gastroenterology; 2023 Feb; 164(2):198-213. PubMed ID: 36309208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota and Colorectal Cancer: From Gut to Bedside.
    Silva M; Brunner V; Tschurtschenthaler M
    Front Pharmacol; 2021; 12():760280. PubMed ID: 34658896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microbiome and precision oncology: an emerging paradigm in anticancer therapy.
    Bhat SA; Kaur R; Chauhan A; Pal A
    Crit Rev Microbiol; 2022 Nov; 48(6):770-783. PubMed ID: 35164642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.